Powered By
Overview
As recently as 20 years ago, doctors discouraged people with multiple sclerosis (MS) from being physically active. Exercise was deemed too dangerous. However, in recent years, many studies have proven that… read more
Overview
As many as 80 percent of people with multiple sclerosis (MS) choose to incorporate non-traditional therapies into their treatment plan. These treatments may be in addition to (complementary) or instead of… read more
Overview
Ocrevus Zunovo is approved by the U.S. Food and Drug Administration (FDA) for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active…
Overview
Copaxone is a prescription medication approved by the Food and Drug Administration (FDA) for treating adults who have had their first episode of multiple sclerosis (MS) symptoms and whose magnetic resonance… read more
Overview
Gilenya is a prescription medication approved by the Food and Drug Administration (FDA) for treating relapsing forms of multiple sclerosis (MS) in adults. Gilenya is also known by its drug name, Fingolimod.… read more
Overview
Aubagio is a prescription medication approved by the Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (MS). It is also known by its drug name, Teriflunomide.… read more
Overview
Betaseron is a prescription medication approved by the Food and Drug Administration (FDA) for adults who have had their first episode of multiple sclerosis (MS) symptoms and whose magnetic resonance imaging… read more
Overview
Glatiramer acetate, sold under the brand name Copaxone, is a prescription medication approved by the Food and Drug Administration (FDA) for treating adults who have had one multiple sclerosis (MS) episode and… read more
Overview
Natalizumab, sold under the brand name Tysabri, is a prescription medication approved by the Food and Drug Administration (FDA) for treating adults with multiple sclerosis (MS). Natalizumab is not a cure for… read more
Overview
Extavia is a prescription medication approved by the Food and Drug Administration (FDA) for adults who have had their first episode of multiple sclerosis (MS) symptoms and whose magnetic resonance imaging (MRI)… read more
Join
